Cyrus Biotechnology
Operator of a biologic therapeutics company intended to treat serious diseases through advanced protein engineering. The company offers an internal immunogenicity redesign platform, combined with prop...
Valuation
$0
Share Price
N/A
Total Raised
$36.6M
Last Round
N/A